About the Authors

Sara Alvarez

salvarez@cnio.es (SA); jccigudosa@cnio.es (JCC)

Affiliation Molecular Cytogenetics Group, Centro Nacional Investigaciones Oncologicas (CNIO), Centro de Investigaciones de Enfermedades Raras (CIBERER), Madrid, Spain

Javier Suela

Affiliation Molecular Cytogenetics Group, Centro Nacional Investigaciones Oncologicas (CNIO), Centro de Investigaciones de Enfermedades Raras (CIBERER), Madrid, Spain

Ana Valencia

Affiliation Hematology Service, Hospital Universitario La Fe, Valencia, Spain

Agustín Fernández

Affiliation Cancer Epigenetics and Biology Program, Bellvitge Institute for Biomedical Research-Catalan Institute of Oncology (IDIBELL-ICO), Barcelona, Spain

Mark Wunderlich

Affiliation Division of Experimental Hematology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America

Xabier Agirre

Affiliation Division of Cancer and Area of Cell Therapy and Hematology Service, Foundation for Applied Medical Research, Clínica Universitaria, Universidad de Navarra, Pamplona, Spain

Felipe Prósper

Affiliation Division of Cancer and Area of Cell Therapy and Hematology Service, Foundation for Applied Medical Research, Clínica Universitaria, Universidad de Navarra, Pamplona, Spain

José Ignacio Martín-Subero

Affiliations Cancer Epigenetics and Biology Program, Bellvitge Institute for Biomedical Research-Catalan Institute of Oncology (IDIBELL-ICO), Barcelona, Spain, Institute of Human Genetics, University Hospital Schleswig-Holstein, Campus Kiel, Christian-Albrechts University, Kiel, Germany

Alba Maiques

Affiliation Molecular Cytogenetics Group, Centro Nacional Investigaciones Oncologicas (CNIO), Centro de Investigaciones de Enfermedades Raras (CIBERER), Madrid, Spain

Francesco Acquadro

Affiliation Molecular Cytogenetics Group, Centro Nacional Investigaciones Oncologicas (CNIO), Centro de Investigaciones de Enfermedades Raras (CIBERER), Madrid, Spain

Sandra Rodriguez Perales

Affiliation Molecular Cytogenetics Group, Centro Nacional Investigaciones Oncologicas (CNIO), Centro de Investigaciones de Enfermedades Raras (CIBERER), Madrid, Spain

María José Calasanz

Affiliation Department of Genetics, University of Navarra, Pamplona, Spain

Jose Roman-Gómez

Affiliation Hematology Service, Hospital Universitario Reina Sofia, Córdoba, Spain

Reiner Siebert

Affiliation Institute of Human Genetics, University Hospital Schleswig-Holstein, Campus Kiel, Christian-Albrechts University, Kiel, Germany

James C. Mulloy

Affiliation Division of Experimental Hematology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America

José Cervera

Affiliation Hematology Service, Hospital Universitario La Fe, Valencia, Spain

Miguel Angel Sanz

Affiliation Hematology Service, Hospital Universitario La Fe, Valencia, Spain

Manel Esteller

Affiliation Cancer Epigenetics and Biology Program, Bellvitge Institute for Biomedical Research-Catalan Institute of Oncology (IDIBELL-ICO), Barcelona, Spain

Juan C. Cigudosa

salvarez@cnio.es (SA); jccigudosa@cnio.es (JCC)

Affiliation Molecular Cytogenetics Group, Centro Nacional Investigaciones Oncologicas (CNIO), Centro de Investigaciones de Enfermedades Raras (CIBERER), Madrid, Spain

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: SA JCC. Performed the experiments: JS AV AF MW XA JIMS AM JRG. Analyzed the data: SA JS AV AF XA JIMS AM FA SRP MJC JCM JVC JCC. Contributed reagents/materials/analysis tools: AV AF MW XA FP MJC JRG RS JCM JVC MAS ME. Wrote the paper: SA ME JCC.